BRIACELL THERAPEUTICS CORP: PHASE 3 STUDY PATIENT ENROLLMENT COMPLETION FOR METASTATIC BREAST CANCER PIVOTAL STUDY IS EXPECTED IN MID-2025

Reuters · 10/15 11:50

Please log in to view news